RU99120430A - HYPOBAROTHERAPY OF ANXIETY DISORDERS IN NEUROSIS AND PSYCHOSOMATIC DISEASES - Google Patents

HYPOBAROTHERAPY OF ANXIETY DISORDERS IN NEUROSIS AND PSYCHOSOMATIC DISEASES

Info

Publication number
RU99120430A
RU99120430A RU99120430/14A RU99120430A RU99120430A RU 99120430 A RU99120430 A RU 99120430A RU 99120430/14 A RU99120430/14 A RU 99120430/14A RU 99120430 A RU99120430 A RU 99120430A RU 99120430 A RU99120430 A RU 99120430A
Authority
RU
Russia
Prior art keywords
hypobarotherapy
neurosis
anxiety disorders
psychosomatic diseases
rise
Prior art date
Application number
RU99120430/14A
Other languages
Russian (ru)
Other versions
RU2193382C2 (en
Inventor
Алексей Анатольевич Атаманов
Владимир Андреевич Буйков
Original Assignee
Челябинская государственная медицинская академия
Filing date
Publication date
Application filed by Челябинская государственная медицинская академия filed Critical Челябинская государственная медицинская академия
Priority to RU99120430A priority Critical patent/RU2193382C2/en
Priority claimed from RU99120430A external-priority patent/RU2193382C2/en
Publication of RU99120430A publication Critical patent/RU99120430A/en
Application granted granted Critical
Publication of RU2193382C2 publication Critical patent/RU2193382C2/en

Links

Claims (1)

Способ лечения тревожных расстройств при неврозах и психосоматических заболеваниях путем гипобаротерапии (адаптации к периодической гипоксии в условиях барокамеры), отличающийся тем, что скорость "подъема" составляет 1-3 м/с, первоначальная "высота подъема" составляет 500 м, а продолжительность одного сеанса - 1,5 ч с учетом времени "подъема" и "спуска".A method of treating anxiety disorders in neurosis and psychosomatic diseases by hypobarotherapy (adaptation to periodic hypoxia in a pressure chamber), characterized in that the speed of "rise" is 1-3 m / s, the initial "height of rise" is 500 m, and the duration of one session - 1.5 hours, taking into account the time of "rise" and "descent".
RU99120430A 1999-09-27 1999-09-27 Hypobarotherapy of anxiety disorders at neurosis and psychosomatic diseases RU2193382C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU99120430A RU2193382C2 (en) 1999-09-27 1999-09-27 Hypobarotherapy of anxiety disorders at neurosis and psychosomatic diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU99120430A RU2193382C2 (en) 1999-09-27 1999-09-27 Hypobarotherapy of anxiety disorders at neurosis and psychosomatic diseases

Publications (2)

Publication Number Publication Date
RU99120430A true RU99120430A (en) 2001-07-20
RU2193382C2 RU2193382C2 (en) 2002-11-27

Family

ID=20225253

Family Applications (1)

Application Number Title Priority Date Filing Date
RU99120430A RU2193382C2 (en) 1999-09-27 1999-09-27 Hypobarotherapy of anxiety disorders at neurosis and psychosomatic diseases

Country Status (1)

Country Link
RU (1) RU2193382C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2593345C2 (en) * 2014-10-21 2016-08-10 Федеральное государственное бюджетное учреждение науки Институт физиологии им. И.П. Павлова Российской академии наук (ИФ РАН) Method for improving cognitive functions

Similar Documents

Publication Publication Date Title
EP0959046A4 (en) Apparatus for purification of water area
BG107537A (en) Method for the inhibition of human tnf alpha activity and its application
CA2286671A1 (en) Method and formulation for treating vascular disease
CA2272584A1 (en) Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
IL113873A0 (en) Novel uses of triplex forming oligonucleotides for the treatment of human diseases
IT9067240A0 (en) PROCEDURE FOR THE ELECTROSTIMULATION OF A MUSCLE MASS IN ORDER TO IMPROVE ITS AESTHETIC APPEARANCE, AND APPARATUS FOR THE IMPLEMENTATION OF THE PROCEDURE
DK0777482T3 (en) Combination preparation for the treatment of immune disorders
CA2333024A1 (en) Method for the treatment of insomnia
CS29990A3 (en) Racemic or optically active bis-aza-bicyclic compounds, process forpreparing thereof, intermediates and use
EP0242580A3 (en) Use of a, b and c prostaglandins and derivatives thereof to treat ocular hypertension and glaucoma
DE122009000036I2 (en) Use of dapoxetine, a selective serotonin uptake inhibitor, for the treatment of sexual dysfunction
ATE283019T1 (en) ORAL STIMULATOR
RU99120430A (en) HYPOBAROTHERAPY OF ANXIETY DISORDERS IN NEUROSIS AND PSYCHOSOMATIC DISEASES
FR2768325B1 (en) CATHETER FOR ARTIFICIAL INSEMINATION OF BIRDS, ESPECIALLY TURKEYS, AND METHOD FOR PRODUCING SUCH A CATHETER
DE69007065D1 (en) Use of diadenosine 5 ', 5' '' - p1, p4-tetraphosphate for the manufacture of a medicament for the treatment of heart diseases.
EP1520859A3 (en) Hydrophilic signal oligopeptides and methods of therapeutic use
FR2729820B1 (en) DEVICE FOR TREATING A HETEROGENEOUS MIXTURE, PARTICULARLY HONEY AND WAX
DE69525841D1 (en) METHOD AND MEDICINE TO REDUCE THE JET LAG
FR2619713B1 (en) APPLICATION OF AMINO-2 TRIFLUOROMETHOXY-6 BENZOTHIAZOLE TO OBTAIN MEDICINE FOR THE TREATMENT OF SLEEP AND DEPRESSION DISORDERS
DE69308762D1 (en) Treatment of muscle loss
NZ335057A (en) Pentaerythritol derivatives, their production and use and intermediates for their synthesis
FR2802811B1 (en) PROCESS FOR EXTRACTING AN ACTIVE INGREDIENT FROM BIGARADE PETALS, PARTICULARLY FOR THE TREATMENT OF CELLULITE, ACTIVE INGREDIENT OBTAINED, COSMETIC COMPOSITIONS AND SUITABLE TREATMENTS
ITRM950589A0 (en) USE OF NATURAL CYTOKINE MUTEINS AS IMMUNOGENS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS TO TREAT OR PREVENT DISEASES CAUSED BY THE OVERPRODUCTION OF THESE NATURAL CYTOKINES, AND PHARMACEUTICAL COMPOSITIONS SO OBTAINABLE
RU96122561A (en) METHOD FOR COMPLEX THERAPY OF DISEASES
SE9000658D0 (en) METHOD FOR TREATMENT OF SLEEP APNOE